CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 4 Open-market sale 10% owner sold 4,912,899 shares at $24.98 ($122,706,039)
- 4 Open-market sale CEO and Chairman sold 33,360 shares at an average $30.71 ($1,024,586)
- 4 Open-market sale Director sold 345,000 shares at $26.50 ($9,142,500)
- 4 Conversion Director acquired 2,217,101 shares (conversion)
- 8-K/A Event Exhibits
- 424B4 Offering Prospectus
- 8-K Event Results of operations · Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- 4 Open-market sale Chief Scientific Officer sold 11,100 shares at an average $28.77 ($319,329)
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale SVP and General Counsel sold 662 shares at $30.00 ($19,860)
- 4 Open-market sale Chief Financial Officer sold 20,000 shares at $29.87 ($597,400)
- 3 Insider Initial Statement of Ownership
- DRS Other Draft Registration Statement
- 8-K Event Regulation FD disclosure
- 4/A Open-market sale Director sold 5,000 shares at $30.00 ($150,000)
Page 38 of 42 · 837 filings